French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia

被引：0

作者：

Pascale Trioche

Brigitte Nelken

Gérard Michel

Isabelle Pellier

Arnaud Petit

Yves Bertrand

Pierre Rohrlich

Claudine Schmitt

Nicolas Sirvent

Patrick Boutard

Geneviève Margueritte

Brigitte Pautard

Stéphane Ducassou

Dominique Plantaz

Alain Robert

Caroline Thomas

Kristell Desseaux

Sylvie Chevret

André Baruchel

机构：

[1] Service de Pédiatrie,Department of Pediatric, APHP, Hôpital Antoine Béclère

[2] CHU,APHP, Hôpital Saint

[3] Hôpital La Timone,Louis, Département de Biostatistique et Informatique Médicale

[4] APHM,APHP, Hôpital Robert Debré

[5] CHU,undefined

[6] APHP,undefined

[7] Hôpital Armand Trousseau,undefined

[8] CHU,undefined

[9] CHU,undefined

[10] CHU,undefined

[11] CHU,undefined

[12] CHU,undefined

[13] CHU,undefined

[14] CHU,undefined

[15] CHU,undefined

[16] CHU,undefined

[17] CHU,undefined

[18] CHU,undefined

[19] Paris et Université Paris Diderot,undefined

[20] Hématologie et Immunologie Pédiatrique,undefined

[21] Paris,undefined

[22] et Université Paris Diderot,undefined

来源：

Experimental Hematology & Oncology | / 1卷 / 1期

关键词：

Acute lymphoblastic leukaemia; Childhood leukaemia; Refractory; Relapsed; Leukaemia; Clofarabine;

D O I：

10.1186/2162-3619-1-39

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] ImatinibIn Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
Sarah A. Cross
Katherine A. Lyseng-Williamson
Drugs, 2007, 67 : 2645 - 2654
[32] Imatinib - In relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia
Cross, Sarah A.
Lyseng-Williamson, Katherine A.
DRUGS, 2007, 67 (17) : 2645 - 2654
[33] Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study
Mondesir, Johanna
Alary, Anne-Sophie
Sibon, David
Willems, Lise
Deau, Benedicte
Suarez, Felipe
Hermine, Olivier
Fontenay, Michaela
Bouscary, Didier
Kosmider, Olivier
Tamburini, Jerome
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (01) : 65 - 72
[34] Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome
Meyr, Franziska
Escherich, Gabriele
Mann, Georg
Klingebiel, Thomas
Kulozik, Andreas
Rossig, Claudia
Schrappe, Martin
Henze, Guenter
von Stackelberg, Arend
Hitzler, Johann
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) : 98 - 106
[35] The long term outcome for children with relapsed acute lymphoblastic leukaemia (ALL).
Russell, S
Williams, S
Vowels, M
BLOOD, 1998, 92 (10) : 512A - 512A
[36] Clofarabine in paediatric patients with acute lymphoblastic leukaemia: profile report
Drugs & Therapy Perspectives, 2006, 22 (4) : 3 - 5
[37] Phase I and Extension Study of Clofarabine Plus Cyclophosphamide in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Faderl, Stefan
Balakrishnan, Kumudha
Thomas, Deborah A.
Ravandi, Farhad
Borthakur, Gautam
Burger, Jan
Ferrajoli, Alessandra
Cortes, Jorge
O'Brien, Susan
Kadia, Tapan
Feliu, Jennie
Plunkett, William
Gandhi, Varsha
Kantarjian, Hagop M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (03): : 231 - 238
[38] The Role of Clofarabine in the Treatment of Relapsed Childhood Acute Lymphoblastic Leukemia
Goto, Hiroaki
Kada, Akiko
Toyoda, Hidemi
Ogawa, Chitose
Horibe, Keizo
PEDIATRIC BLOOD & CANCER, 2021, 68
[39] PHASE I/II TRIAL OF MITOXANTRONE AND CLOFARABINE IN CHILDREN WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA
Hochberg, Jessica
Oesterheld, Javier
Gardenswartz, Aliza
Klejmont, Liana
Harrison, Lauren
Basso, Jaclyn
Borowitz, Michael
Loken, Michael
Cairo, Mitchell
PEDIATRIC BLOOD & CANCER, 2022, 69
[40] Real-world experience managing blinatumomab toxicities in adults with relapsed/refractory acute lymphoblastic leukemia
Crist, MacKenzie
Emadi, Ashkan
Duffy, Alison
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) : 1080 - 1085

← 1 2 3 4 5 →